Saturday, October 17, 2020 12:52:37 PM
1. Eli Lilly is having problems with its monoclonal antibody for COVID.
https://finance.yahoo.com/news/eli-lily-covid-19-antibody-014246420.html
2. Lilly Asia ventures owns a large proportion of ACEA Therapeutics.
"Lilly Asia Ventures, founded in 2008, is dedicated to venture capital investments in the life sciences and healthcare sectors in Asia, particularly in China. Its investors include Eli Lilly & Co., a Fortune 500 company and one of the most globalized and innovative pharmaceutical companies in the world. As a leading biomedical venture fund in China, Lilly Asia Ventures provides wise capital, industry expertise, and global resources to its portfolio companies to accelerate their growth.
www.lillyasiaventures.com »"
3. Eli Lilly knows about Sorrento's excellent antibodies for Covid and cancer. It will sell ACEA to Sorrento only to later turn around and buyout Sorrento!
Stranger things have happened. And I would at least put Eli Lilly on the list of Big Pharmas who would be interested in acquiring Sorrento!
"The refusal of the real is the number one dogma of our time" Rene Girard
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM